In a recent transaction, Allen S. Melemed, the Chief Medical (TASE:PMCN) Officer of Chimerix Inc . (NASDAQ:CMRX), sold 3,065 shares of the company's common stock. The shares were sold at an average ...

Michael T. Andriole, President and CEO of Chimerix Inc . (NASDAQ:CMRX), recently sold 7,370 shares of the company's common stock, according to a recent SEC filing. The shares were sold at a weighted ...

Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...

United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Stock analysts at Leerink Partnrs reduced their FY2024 EPS estimates for shares of United Therapeutics in a research note issued on Tuesday, February 11th. Leerink Partnrs analyst R. Ruiz now expects ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...